Key facts
- APVO - Aptevo Therapeutics Inc. has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: +$20,134.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of Aptevo Therapeutics Inc.
- Symbol
- APVO on Nasdaq
- Location
- Seattle, WA
Change
- Buy value: $20,134; sell value: $0.
- Net share flow: +13,513.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$20,134.
Buys
$20,134
Shares: 13,513
Insiders: 1
Sells
$0
Shares: 0
Insiders: 0
Net
+$20,134
Shares: +13,513
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 13,513 | 0 | $20,134 | $0 | +$20,134 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Aptevo Therapeutics Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Grady Grant III | Director | $20,135 | +$20,134 | +2013400% | Filing P/S | 10 Nov 2025 |
| BANK OF AMERICA CORP /DE/ | 10%+ Owner | $82 | Mixed | 01 Oct 2025 | ||
| Marvin L. White | President and CEO, Director | $3 | Market | 06 Aug 2025 | ||
| SoYoung Kwon | SVP, GC, BD & Corp Affairs | $1 | Market | 06 Aug 2025 | ||
| Jeffrey G. Lamothe | Evp, Coo | $1 | Market | 06 Aug 2025 | ||
| Dirk Huebner | Svp, Cmo | $0 | Mixed | 06 Aug 2025 | ||
| Zsolt Harsanyi | Director | $0 | Mixed | 06 Aug 2025 | ||
| John Niederhuber | Director | $0 | Mixed | 06 Aug 2025 | ||
| Daniel Abdun-Nabi | Director | $0 | Mixed | 06 Aug 2025 | ||
| Daphne Taylor | Svp, Cfo | $0 | Mixed | 06 Aug 2025 | ||
| Barbara Lopez Kunz | Director | $0 | Mixed | 06 Aug 2025 | ||
| Kevin Tang | Exit Filing | Mixed | 23 Nov 2021 | |||
| Fuad El-Hibri | Director | Mixed | 03 Dec 2021 |
Top shareholders of Aptevo Therapeutics Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
— |
10%
|
358,150
|
$107,445 | $0 | 30 Jun 2025 | |
| YA II PN, Ltd. |
13D/G
|
— |
10%
|
357,842
|
$1,663,965 | $0 | 16 Jun 2025 | |
| BIGGER CAPITAL FUND L P |
13D/G
|
— |
10%
|
285,000
|
— | $0 | 18 Jun 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
8.2%
|
83,854
|
$744,624 | $0 | 31 Dec 2025 | |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
— |
5%
|
164,300
|
$492,900 | -$362,100 | 14 Aug 2025 | |
| Hudson Bay Capital Management LP |
13D/G
|
— |
5%
|
76,598
|
$52,853 | $0 | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13D/G
3/4/5
|
10%+ Owner |
0%
|
86
|
$125 | -$715,879 | 31 Oct 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
1.9%
|
19,638
|
$84,000 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
13,337
|
$56,948 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
12,713
|
$54,285 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.41%
|
4,142
|
$17,686 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.34%
|
3,445
|
$14,710 | — | 31 Mar 2026 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
360
|
$1,535 | — | 31 Mar 2026 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.01%
|
109
|
$465 | — | 31 Mar 2026 | |
| CWM, LLC |
13F
|
Company |
0%
|
5
|
$21 | — | 31 Mar 2026 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Mar 2026 | |
| Grady Grant III |
3/4/5
|
Director |
—
mixed-class rows
|
20,714
mixed-class rows
|
$20,135 | +$20,134 | 10 Nov 2025 | |
| Marvin L. White |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
30,012
mixed-class rows
|
$3 | — | 06 Aug 2025 | |
| Jeffrey G. Lamothe |
3/4/5
|
EVP, COO |
—
mixed-class rows
|
17,306
mixed-class rows
|
$1 | — | 06 Aug 2025 | |
| SoYoung Kwon |
3/4/5
|
SVP, GC, BD & Corp Affairs |
—
mixed-class rows
|
11,504
mixed-class rows
|
$1 | — | 06 Aug 2025 | |
| Fuad El-Hibri |
3/4/5
|
Director |
—
class O/S missing
|
87,697
|
— | — | 03 Dec 2021 | |
| Daphne Taylor |
3/4/5
|
SVP, CFO |
—
mixed-class rows
|
11,503
mixed-class rows
|
— | — | 06 Aug 2025 | |
| Dirk Huebner |
3/4/5
|
SVP, CMO |
—
class O/S missing
|
11,500
|
— | — | 06 Aug 2025 | |
| Barbara Lopez Kunz |
3/4/5
|
Director |
—
mixed-class rows
|
7,201
mixed-class rows
|
— | — | 06 Aug 2025 | |
| Daniel Abdun-Nabi |
3/4/5
|
Director |
—
mixed-class rows
|
7,201
mixed-class rows
|
— | — | 06 Aug 2025 | |
| John Niederhuber |
3/4/5
|
Director |
—
mixed-class rows
|
7,201
mixed-class rows
|
— | — | 06 Aug 2025 | |
| Zsolt Harsanyi |
3/4/5
|
Director |
—
mixed-class rows
|
7,201
mixed-class rows
|
— | — | 06 Aug 2025 |
Recent Insider Transactions by Companies or Individuals for Aptevo Therapeutics Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Grady Grant III | APVO | Common Stock | Purchase | 1351300% | $20,134 | $1.49 | 13,513 | 13,514 | 10 Nov 2025 | Direct |
| Daniel Abdun-Nabi | APVO | Restricted Stock Unit | Award | 7,200 | 7,200 | 06 Aug 2025 | Direct | |||
| Daphne Taylor | APVO | Restricted Stock Unit | Award | 11,500 | 11,500 | 06 Aug 2025 | Direct | |||
| Grady Grant III | APVO | Restricted Stock Unit | Award | 7,200 | 7,200 | 06 Aug 2025 | Direct | |||
| Dirk Huebner | APVO | Restricted Stock Unit | Award | 11,500 | 11,500 | 06 Aug 2025 | Direct | |||
| John Niederhuber | APVO | Restricted Stock Unit | Award | 7,200 | 7,200 | 06 Aug 2025 | Direct | |||
| Jeffrey G. Lamothe | APVO | Restricted Stock Unit | Award | 17,300 | 17,300 | 06 Aug 2025 | Direct | |||
| Marvin L. White | APVO | Restricted Stock Unit | Award | 30,000 | 30,000 | 06 Aug 2025 | Direct | |||
| Barbara Lopez Kunz | APVO | Restricted Stock Unit | Award | 7,200 | 7,200 | 06 Aug 2025 | Direct | |||
| SoYoung Kwon | APVO | Restricted Stock Unit | Award | 11,500 | 11,500 | 06 Aug 2025 | Direct | |||
| Zsolt Harsanyi | APVO | Restricted Stock Unit | Award | 7,200 | 7,200 | 06 Aug 2025 | Direct | |||
| Zsolt Harsanyi | APVO | Common Stock | Options Exercise | 1 | 1 | 17 Jul 2025 | Direct | |||
| Zsolt Harsanyi | APVO | Restricted Stock Unit | Options Exercise | -100% | -1 | 0 | 17 Jul 2025 | Direct | ||
| Barbara Lopez Kunz | APVO | Common Stock | Options Exercise | 1 | 1 | 17 Jul 2025 | Direct | |||
| Barbara Lopez Kunz | APVO | Restricted Stock Unit | Options Exercise | -100% | -1 | 0 | 17 Jul 2025 | Direct | ||
| Daniel Abdun-Nabi | APVO | Common Stock | Options Exercise | 1 | 1 | 17 Jul 2025 | Direct | |||
| Daniel Abdun-Nabi | APVO | Restricted Stock Unit | Options Exercise | -100% | -1 | 0 | 17 Jul 2025 | Direct | ||
| Grady Grant III | APVO | Common Stock | Options Exercise | 1 | 1 | 17 Jul 2025 | Direct | |||
| Grady Grant III | APVO | Restricted Stock Unit | Options Exercise | -100% | -1 | 0 | 17 Jul 2025 | Direct | ||
| John Niederhuber | APVO | Common Stock | Options Exercise | 1 | 1 | 17 Jul 2025 | Direct | |||
| John Niederhuber | APVO | Restricted Stock Unit | Options Exercise | -100% | -1 | 0 | 17 Jul 2025 | Direct | ||
| Daphne Taylor | APVO | Common Stock | Options Exercise | 3 | 3 | 17 Jul 2025 | Direct | |||
| Daphne Taylor | APVO | Restricted Stock Unit | Options Exercise | -27.3% | -3 | 8 | 17 Jul 2025 | Direct | ||
| SoYoung Kwon | APVO | Common Stock | Options Exercise | 300% | 3 | 4 | 17 Jul 2025 | Direct | ||
| SoYoung Kwon | APVO | Restricted Stock Unit | Options Exercise | -27.3% | -3 | 8 | 17 Jul 2025 | Direct | ||
| Marvin L. White | APVO | Common Stock | Options Exercise | 500% | 10 | 12 | 17 Jul 2025 | Direct | ||
| Marvin L. White | APVO | Restricted Stock Unit | Options Exercise | -33.3% | -10 | 20 | 17 Jul 2025 | Direct | ||
| Jeffrey G. Lamothe | APVO | Common Stock (post-reverse split May ACTIVE) | Options Exercise | 500% | 5 | 6 | 17 Jul 2025 | Direct | ||
| Jeffrey G. Lamothe | APVO | Restricted Stock Unit | Options Exercise | -29.4% | -5 | 12 | 17 Jul 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.